Jonathan Silverstein

Jonathan Silverstein, JD, joined OrbiMed Advisors, LLC in 1998 to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies. Mr. Silverstein was a Director of Life Sciences in the Investment Banking Department at the Sumitomo Bank and an Associate at Hambro Resource Development. Mr. Silverstein has a JD and an MBA from the University of San Diego, and a BA in Economics from Denison University. Currently, Mr. Silverstein is the Chairman of Enobia Pharma, Inc., Cerapedics, Inc., and Gelesis, and he is a Director at superDimension, Ltd., Glaukos Corporation and Nxstage Medical, Inc. He has been a Director or observer in more than a dozen other companies, including: LifeCell Corporation, Given Imaging, Ltd., Cerexa, Inc. (sold to Forest Laboratories, Inc.), Peninsula Pharmaceuticals, Inc. (sold to Johnson & Johnson, Inc.), Predix Pharmaceuticals, Inc.(sold to Epix Pharmaceuticals, Inc.), Avanir Pharmaceuticals, Inc., Orthovita, Inc., Auxillium Pharmaceuticals, Inc., Bioenvision (sold to Genzyme Corporation), Adiana, Inc. (sold to Cytyc Corporation) and Adolor Corporation.